We firmly believe that everybody has the basic human right to live without the limitations of disease. Therefore, we aim to provide patients with new treatment options that add true value and allow them to break free from those limitations.

From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Preventing pressure ulcers with smart monitoring

MoVax develops oral vaccines. The vaccine survives the gastrointestinal tract because of bio-encapsulation the API inside microbial cells. Microalgae are a highly promising delivery platform for oral vaccines.

At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.

Nanoporous MicroNeedle Arrays (npMNAs), integrated into a patch for drug delivery through the skin

MyMicroZoo™ is a company that offers microbiome analysis and web-based tools to gather meta-data (e.g. age, health-status, exercise logs, etc.) as service to the general public, allowing them to gain knowledge and understanding of their microbiota through an innovative platform.

Humanised muscle models for preclinical testing - Leading in compound selection for neuromuscular disorders.